Exosomal long non-coding RNAs in glioblastoma
Clinica Chimica Acta · 2024
DOI: 10.1016/j.cca.2023.117705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinica Chimica Acta, 2024. Verfasst von Mehdi Fattahi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam; School of Engineering & Technology, Duy Tan University, Da Nang, Viet N…. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most prevalent primary tumor found in the central nervous system, accounting for 70% of all adult brain tumors. The median overall survival rate is one year post-diagnosis with treatment, and only four months without treatment. Current GBM diagnostic methods, such as magnetic resonance imaging (MRI), surgery, and brain biopsies, have limitations. These include difficulty distinguishing between tumor recurrence and post-surgical necrotic regions, and operative risks associated with obtaining histological samples through direct surgery or biopsies. Consequently, there is a need for rapid, inexpensive, and minimally invasive techniques for early diagnosis and improved subsequent treatment. Research has shown that tumor-derived exosomes containing various long non-coding RNAs (lncRNAs) play critical regulatory roles in immunomodulation, cancer metastasis, cancer development, and drug resistance in GBM. They regulate genes that enhance cancer growth and progression and alter the expression of several key signaling pathways. Due to the specificity and sensitivity of exosomal lncRNAs, they have the potential to be used as biomarkers for early diagnosis and prognosis, as well as to monitor a patient's response to chemotherapy for GBM. In this review, we discuss the role of exosomal lncRNAs in the pathogenesis of GBM and their potential clinical applications for early diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam; School of Engineering & Technology, Duy Tan University, Da Nang, Viet Nam.
- Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran.
Zitieren
APA
Fattahi, M., Alamdari-Palangi, V., Rahimi Jaberi, K., Ehtiati, S., Ojaghi, S., Rahimi-Jaberi, A., Samavarchi Tehrani, S., Dang, P., Movahedpour, A., & Hossein Khatami, S. (2024). Exosomal long non-coding RNAs in glioblastoma. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2023.117705
Vancouver
Fattahi M, Alamdari-Palangi V, Rahimi Jaberi K, Ehtiati S, Ojaghi S, Rahimi-Jaberi A, et al. Exosomal long non-coding RNAs in glioblastoma. Clinica Chimica Acta. 2024. doi:10.1016/j.cca.2023.117705
BibTeX
@article{Fattahi2024,
author = {Fattahi, Mehdi and Alamdari-Palangi, Vahab and Rahimi Jaberi, Khojaste and Ehtiati, Sajad and Ojaghi, Sara and Rahimi-Jaberi, Abbas and Samavarchi Tehrani, Sadra and Dang, Phuyen and Movahedpour, Ahmad and Hossein Khatami, Seyyed},
title = {Exosomal long non-coding RNAs in glioblastoma},
journal = {Clinica Chimica Acta},
year = {2024},
doi = {10.1016/j.cca.2023.117705}
}
EUVIMED